MedTrace Logo

Pain After Buffered Vs Non Buffered Articaine

NCT06538233 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-08-05

No results posted yet for this study

Summary

Pain after buffered versus non buffered articaine.

Conditions

Interventions

DRUG

Buffered articaine

Injecting buffered articaine in maxillary anterior region and evaluate pain response.

DRUG

Non buffered articaine

Injecting non buffered articaine in maxillary anterior region and evaluate pain response.

Sponsors & Collaborators

  • Cleveland Dental Institute

    lead OTHER

Principal Investigators

  • Ahmed H Khalifa, PhD · Cleveland Dental Institute

  • Waleed Elmallah, PhD · Cleveland Dental Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-10-31
Completion
2025-01-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06538233 on ClinicalTrials.gov